These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3539644)

  • 41. Male hypogonadism.
    Bain J
    Compr Ther; 1983 Feb; 9(2):17-24. PubMed ID: 6404588
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aspects of the differential diagnosis of disturbances in the hypothalamus-pituitary-gonad axis with special regard to the diagnostic and therapeutic use of gonadotropin releasing hormone (author's transl)].
    Lunenfeld B; Glezerman M
    Wien Klin Wochenschr; 1974 May; 86(9):233-44. PubMed ID: 4596633
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypothalamic-releasing hormones: therapeutic potential of gonadotrophin-releasing hormone: a review.
    Clayton RN
    Q J Med; 1984; 53(209):17-27. PubMed ID: 6369375
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pregnancy provoked by pulsatile administration of gonadotropin- releasing hormone in 2 women with oligomenorrhea].
    Gandar R; Armani J; Baldauf JJ
    Rev Fr Gynecol Obstet; 1985 Jan; 80(1):39-41. PubMed ID: 3903948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism.
    Snyder PJ; Rudenstein RS; Gardner DF; Rothman JG
    J Clin Endocrinol Metab; 1979 May; 48(5):864-8. PubMed ID: 372209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endometrial biopsies during treatment with subcutaneous pulsatile gonadotropin-releasing hormone and luteal-phase human chorionic gonadotropin.
    Campbell BF; Phipps WR; Nagel TC; Tagatz GE
    Int J Fertil; 1988; 33(5):329-33. PubMed ID: 2904419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.
    Finkelstein JS; Badger TM; O'Dea LS; Spratt DI; Crowley WF
    J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hyperprolactinemic amenorrhea with pulsatile gonadotropin-releasing hormone therapy.
    Gindoff PR; Loucopoulos A; Jewelewicz R
    Fertil Steril; 1986 Dec; 46(6):1156-8. PubMed ID: 3536607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful induction of ovulation with synthetic luteinizing hormone-releasing hormone in anovulatoy infertility.
    Zárate A; Canales ES; Schally AV; Ayala-Valdés L; Kastin AJ
    Fertil Steril; 1972 Sep; 23(9):672-4. PubMed ID: 4559100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of pituitary response to nasal application of synthetic gonadotropin-releasing hormone in men.
    Potashnik G; Ben-Adereth N; Lunenfeld B; Rofe C
    Fertil Steril; 1977 Jun; 28(6):650-4. PubMed ID: 324823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ovulation induction by pulsatile GnRH therapy in 2014: literature review and synthesis of current practice].
    Gronier H; Peigné M; Catteau-Jonard S; Dewailly D; Robin G
    Gynecol Obstet Fertil; 2014 Oct; 42(10):732-40. PubMed ID: 25245838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies in the use of luteinizing hormone-follicle-stimulating hormone releasing hormone to induce ovulation in women.
    Bonnar J
    J Endocrinol; 1973 Aug; 58(2):XXXIV-XXXV. PubMed ID: 4580059
    [No Abstract]   [Full Text] [Related]  

  • 54. Empty sella in children and adolescents with possible hypothalamic-pituitary disorders.
    Cacciari E; Zucchini S; Ambrosetto P; Tani G; Carlà G; Cicognani A; Pirazzoli P; Sganga T; Balsamo A; Cassio A
    J Clin Endocrinol Metab; 1994 Mar; 78(3):767-71. PubMed ID: 8126155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovulation induction and pregnancy in hypothalamic amenorrhea using self-administered intravenous gonadotropin-releasing hormone.
    Goerzen J; Corenblum B; Wiseman DA; Taylor PJ
    Fertil Steril; 1984 Feb; 41(2):319-21. PubMed ID: 6365602
    [No Abstract]   [Full Text] [Related]  

  • 56. [Disorders of gonadal function in hypothalamic-pituitary diseases].
    Tanaka K; Toriumi M; Shinohara Y; Okazaki R
    Nihon Rinsho; 1997 Nov; 55(11):2969-73. PubMed ID: 9396297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology.
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovulation induction with pulsatile intravenous GnRH.
    Malo JW; Bezdicek B; Campbell E; Pavelka DA; Covato T
    J Reprod Med; 1985 Dec; 30(12):902-6. PubMed ID: 3908673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
    Blunt SM; Butt WR
    Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.
    Homburg R; Eshel A; Armar NA; Tucker M; Mason PW; Adams J; Kilborn J; Sutherland IA; Jacobs HS
    BMJ; 1989 Mar; 298(6676):809-12. PubMed ID: 2496866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.